公开(公告)号：US09216972B2

公开(公告)日：2015-12-22

申请号：US13504541

申请日：2010-10-29

申请人： T. G. Murali Dhar ,  Hai-Yun Xiao ,  Scott Hunter Watterson ,  Soo S. Ko ,  Alaric J. Dyckman ,  Charles M. Langevine ,  Jagabandhu Das ,  Robert J. Cherney

发明人： T. G. Murali Dhar ,  Hai-Yun Xiao ,  Scott Hunter Watterson ,  Soo S. Ko ,  Alaric J. Dyckman ,  Charles M. Langevine ,  Jagabandhu Das ,  Robert J. Cherney

IPC分类号： C07D413/04 ,  C07D231/54 ,  C07D261/20 ,  C07D277/84 ,  C07D403/06 ,  C07D413/06 ,  C07D413/14 ,  C07D417/04 ,  C07D417/14 ,  C07D419/04 ,  C07D487/10 ,  C07D498/04

CPC分类号： C07D413/04 ,  C07D231/54 ,  C07D261/20 ,  C07D277/84 ,  C07D403/06 ,  C07D413/06 ,  C07D413/14 ,  C07D417/04 ,  C07D417/14 ,  C07D419/04 ,  C07D487/10 ,  C07D498/04

摘要： Disclosed are compounds of Formula (I) or stereoisomers or salts thereof, wherein: X1, X2, X3, W, Q1, Q2, and G2 are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

摘要翻译： 公开了式（I）的化合物或其立体异构体或其盐，其中：X1，X2，X3，W，Q1，Q2和G2在本文中定义。 还公开了使用这种化合物作为G蛋白偶联受体S1P1的选择性激动剂的方法，以及包含这些化合物的药物组合物。 这些化合物可用于治疗，预防或减缓各种治疗领域（例如自身免疫疾病和血管疾病）中的疾病或病症的进展。

公开(公告)号：US20120214767A1

公开(公告)日：2012-08-23

申请号：US13504541

申请日：2010-10-29

申请人： T.G. Murali Dhar ,  Hai-Yun Xiao ,  Scott Hunter Watterson ,  Soo S. Ko ,  Alaric J. Dyckman ,  Charles M. Langevine ,  Jagabandhu Das

发明人： T.G. Murali Dhar ,  Hai-Yun Xiao ,  Scott Hunter Watterson ,  Soo S. Ko ,  Alaric J. Dyckman ,  Charles M. Langevine ,  Jagabandhu Das

IPC分类号： A61K31/423 ,  C07D498/04 ,  A61K31/454 ,  C07D413/04 ,  A61P37/00 ,  A61K31/5377 ,  C07F9/09 ,  A61K31/675 ,  A61P35/00 ,  A61P7/00 ,  C07D413/14 ,  A61K31/506

CPC分类号： C07D413/04 ,  C07D231/54 ,  C07D261/20 ,  C07D277/84 ,  C07D403/06 ,  C07D413/06 ,  C07D413/14 ,  C07D417/04 ,  C07D417/14 ,  C07D419/04 ,  C07D487/10 ,  C07D498/04

摘要： Disclosed are compounds of Formula (I) or stereoisomers or salts thereof, wherein: X1, X2, X3, W, Q1, Q2, and G2 are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

摘要翻译： 公开了式（I）的化合物或其立体异构体或其盐，其中：X1，X2，X3，W，Q1，Q2和G2在本文中定义。 还公开了使用这种化合物作为G蛋白偶联受体S1P1的选择性激动剂的方法，以及包含这些化合物的药物组合物。 这些化合物可用于治疗，预防或减缓各种治疗领域（例如自身免疫性疾病和血管疾病）中的疾病或病症的进展。

公开(公告)号：US08067447B2

公开(公告)日：2011-11-29

申请号：US12513192

申请日：2007-10-31

申请人： James E. Sheppeck ,  John L. Gilmore ,  T. G. Murali Dhar ,  Hai-Yun Xiao

发明人： James E. Sheppeck ,  John L. Gilmore ,  T. G. Murali Dhar ,  Hai-Yun Xiao

IPC分类号： A61K31/433 ,  A61K31/416 ,  C07D285/135 ,  C07D231/56 ,  C07D231/40

CPC分类号： C07D231/56 ,  C07D401/12 ,  C07D403/12 ,  C07D405/12 ,  C07D409/12 ,  C07D417/12 ,  C07D417/14

摘要： Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, and/or AP-1, and/or NF-κB activity including inflammatory and immune diseases, obesity and diabetes having the structure of formula (I), its enantiomers, diastereomers, or a pharmaceutically-acceptable salt, or hydrate, thereof, wherein (Ia) is heterocycle or heteroaryl; J, Ja, E, F, G, Ma, M, Q, Za and Z are as defined herein. Also provided are pharmaceutical compositions and methods of treating inflammatory- or immune-associated diseases and obesity and diabetes employing said compounds.

摘要翻译： 提供了新的非甾体化合物，其可用于治疗与调节糖皮质激素受体，和/或AP-1和/或NF-κB活性相关的疾病，包括炎性和免疫疾病，肥胖症和糖尿病，其结构为 式（I），其对映异构体，非对映体或其药学上可接受的盐或水合物，其中（Ia）是杂环或杂芳基; J，Ja，E，F，G，Ma，M，Q，Za和Z如本文所定义。 还提供了使用所述化合物治疗炎性或免疫相关疾病和肥胖症和糖尿病的药物组合物和方法。

公开(公告)号：US08309730B2

公开(公告)日：2012-11-13

申请号：US12741597

申请日：2008-10-30

申请人： T. G. Murali Dhar ,  Hai-Yun Xiao

发明人： T. G. Murali Dhar ,  Hai-Yun Xiao

IPC分类号： A61K31/438 ,  A61K31/4375 ,  C07D471/10 ,  C07D487/04 ,  C07D491/22 ,  C07D471/04

CPC分类号： C07D471/04

摘要： Disclosed are compounds of Formula (I) wherein: one of A and D is —N— and the other of A and D is —C—; or enantiomers, diastereomers, or pharmaceutically-acceptable salts thereof. Also disclosed are methods of using such compounds to modulate the function of glucocorticoid receptor activity and pharmaceutical compositions comprising such compounds.

摘要翻译： 公开了式（I）的化合物，其中：A和D之一是-N-，A和D中的另一个是-C-; 或其对映异构体，非对映异构体或其药学上可接受的盐。 还公开了使用这些化合物调节糖皮质激素受体活性的功能的方法和包含这些化合物的药物组合物。

公开(公告)号：US20100075961A1

公开(公告)日：2010-03-25

申请号：US12513232

申请日：2007-10-31

申请人： James E. Sheppeck ,  John L. Gilmore ,  T. G. Murali Dhar ,  Hai-Yun Xiao ,  Jianmin Wang ,  Bingwei Vera Yang ,  Lidia M. Doweyko

发明人： James E. Sheppeck ,  John L. Gilmore ,  T. G. Murali Dhar ,  Hai-Yun Xiao ,  Jianmin Wang ,  Bingwei Vera Yang ,  Lidia M. Doweyko

IPC分类号： A61K31/416 ,  C07D231/56 ,  C07D413/12 ,  A61K31/5377 ,  A61P3/00 ,  A61P29/00 ,  A61P37/00

CPC分类号： C07D231/56 ,  C07D401/12 ,  C07D403/12 ,  C07D409/12

摘要： Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity including inflammatory and immune diseases, obesity and diabetes having the structure of formula (I), its enantiomers, diastereomers, or a pharmaceutically acceptable salt, or hydrate, thereof, wherein X is (Ia); or X is (Ib); or X is (Ic); (Id) is heterocycle or heteroaryl; E is —N—, —NR1—, —O—, —S—, —SO2— or —CR2—; F is —N—, —NR1a—, —O—, —S—, —SO2— or —CR2a—; G is N, —NR1b—, —O—, —S—, —SO2— or —CR2b—, provided that the E-F-G containing heterocyclic ring formed does not contain a S—S or S—O bond, and at least one of E, F and G is a heteroatom; J, Ja, M, Ma, Q, Rx, Ry, R1, R1a, R1b, R2, R2a, R2b, and R3 to R21, Z, Za, Zb, and Zc are as defined above.

摘要翻译： 提供了新的非甾体化合物，其可用于治疗与调节糖皮质激素受体，AP-1和/或NF-κB活性相关的疾病，包括具有式（I）结构的炎性和免疫疾病，肥胖症和糖尿病 ），其对映异构体，非对映异构体或其药学上可接受的盐或水合物，其中X为（Ia）; 或X为（Ib）; 或X为（Ic）; （Id）是杂环或杂芳基; E是-N-，-NR1 - ， - O - ， - S - ， - SO2-或-CR2-; F是-N-，-NR1 - ， - O - ， - S - ， - SO2-或-CR2a-; G是N，-NR1b - ， - O - ， - S - ， - SO2-或-CR2b-，条件是所形成的含有EFG的杂环不含S-S或S-O键， E，F和G是杂原子; J，Ja，M，Ma，Q，Rx，Ry，R1，R1a，R1b，R2，R2a，R2b和R3至R21，Z，Za，Zb和Zc如上所定义。

公开(公告)号：US08198311B2

公开(公告)日：2012-06-12

申请号：US12513232

申请日：2007-10-31

申请人： James E. Sheppeck ,  John L. Gilmore ,  T. G. Murali Dhar ,  Hai-Yun Xiao ,  Jianmin Wang ,  Bingwei Vera Yang ,  Lidia M. Doweyko

发明人： James E. Sheppeck ,  John L. Gilmore ,  T. G. Murali Dhar ,  Hai-Yun Xiao ,  Jianmin Wang ,  Bingwei Vera Yang ,  Lidia M. Doweyko

IPC分类号： A61K31/416 ,  C07D231/56

CPC分类号： C07D231/56 ,  C07D401/12 ,  C07D403/12 ,  C07D409/12

摘要： Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity including inflammatory and immune diseases, obesity and diabetes having the structure of formula (I), its enantiomers, diastereomers, or a pharmaceutically acceptable salt, or hydrate, thereof, wherein X is (Ia); or X is (Ib); or X is (Ic); (Id) is heterocycle or heteroaryl; E is —N—, —NR1—, —O—, —S—, —SO2— or —CR2—; F is —N—, —NR1a—, —O—, —S—, —SO2— or —CR2a—; G is N, —NR1b—, —O—, —S—, —SO2— or —CR2b—, provided that the E-F-G containing heterocyclic ring formed does not contain a S—S or S—O bond, and at least one of E, F and G is a heteroatom; J, Ja, M, Ma, Q, Rx, Ry, R1, R1a, R1b, R2, R2a, R2b, and R3 to R21, Z, Za, Zb, and Zc are as defined above.

摘要翻译： 提供了新的非甾体化合物，其可用于治疗与调节糖皮质激素受体，AP-1和/或NF-κB活性相关的疾病，包括具有式（I）结构的炎性和免疫疾病，肥胖症和糖尿病 ），其对映异构体，非对映异构体或其药学上可接受的盐或水合物，其中X为（Ia）; 或X为（Ib）; 或X为（Ic）; （Id）是杂环或杂芳基; E是-N-，-NR1 - ， - O - ， - S - ， - SO2-或-CR2-; F是-N-，-NR1 - ， - O - ， - S - ， - SO2-或-CR2a-; G是N，-NR1b - ， - O - ， - S - ， - SO2-或-CR2b-，条件是所形成的含有EFG的杂环不含S-S或S-O键， E，F和G是杂原子; J，Ja，M，Ma，Q，Rx，Ry，R1，R1a，R1b，R2，R2a，R2b和R3至R21，Z，Za，Zb和Zc如上所定义。

公开(公告)号：US20100190820A1

公开(公告)日：2010-07-29

申请号：US12513228

申请日：2007-10-31

申请人： T. G. Murali Dhar ,  Hai-Yun Xiao ,  James E. Sheppeck

发明人： T. G. Murali Dhar ,  Hai-Yun Xiao ,  James E. Sheppeck

IPC分类号： A61K31/437 ,  C07D471/04 ,  A61P37/02

CPC分类号： C07D471/04

摘要： Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, and/or AP-1 and/or NF-κB activity including inflammatory and immune diseases, obesity and diabetes having the structure of formula (I): its enantiomers, diastereomers, or a pharmaceutically-acceptable salt, or hydrate, thereof, wherein the group X is O or (Rx)(Ry); is heterocyclo or heteroaryl; E is —N—, —NR1—, —O—, —C(═O), —S—, —SO2—, or —CR2—; F is —N—, —NR1a, —O—, —C(═O), —S—, —SO2—, or —CR2a—; G is independently N, —NR1b—, —O—, —C(═O), —S—, —SO2— or —CR2b— provided that the heterocyclic ring formed does not contain a S—S or S—O bond and at least one of E, F and G is a hetero atom; and Ma, Rx, Ry, R1, R1a, R1b, R2, R2a, R2b, R4, R5a, R6, R7, X, Za and Z are as defined herein. Also provided are pharmaceutical compositions and methods of treating inflammatory- or immune-associated diseases employing said compounds.

摘要翻译： 提供了新的非甾体化合物，其可用于治疗与调节糖皮质激素受体，和/或AP-1和/或NF-κB活性相关的疾病，包括具有结构式的炎性和免疫疾病，肥胖症和糖尿病 （I）：其对映异构体，非对映异构体或其药学上可接受的盐或水合物，其中基团X为O或（Rx）（Ry）; 是杂环基或杂芳基; E是-N-，-NR1-，-O - ， - C（= O）， - S - ， - SO 2 - 或-CR 2 - ; F是-N-，-NR1a，-O-，-C（= O），-S-，-SO2 - 或-CR2a; G独立地为N，-NR1b - ， - O - ， - C（= O）， - S - ， - SO2-或-CR2b-，条件是所形成的杂环不含S-S或S-O键， E，F和G中的至少一个是杂原子; 并且Ma，Rx，Ry，R1，R1a，R1b，R2，R2a，R2b，R4，R5a，R6，R7，X，Za和Z如本文所定义。 还提供了使用所述化合物治疗炎性或免疫相关疾病的药物组合物和方法。

公开(公告)号：US07642273B2

公开(公告)日：2010-01-05

申请号：US11330749

申请日：2006-01-12

申请人： T. G. Murali Dhar ,  Hai-Yun Xiao ,  Bingwei Yang

发明人： T. G. Murali Dhar ,  Hai-Yun Xiao ,  Bingwei Yang

IPC分类号： C07D401/00 ,  C07D249/08 ,  A61K31/44 ,  A01N43/64

CPC分类号： C07D401/10 ,  C07D249/14 ,  C07D277/46 ,  C07D401/04 ,  C07D401/14 ,  C07D403/10 ,  C07D417/10

摘要： A class of novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I) or (II): including a stereoisomer thereof, a tautomer thereof, a prodrug thereof, or a pharmaceutically acceptable salt thereof, where Q is selected from N, O, and S; Y is aryl or heteroaryl; Z is H, C2-6alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, halo, or alkoxy; and A, B, R, Ra, Rb, Rc and Rd are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.

摘要翻译： 提供了一类新型非甾体化合物，其可用于治疗与糖皮质激素受体，AP-1和/或NF-κB活性的调节相关的疾病，包括肥胖症，糖尿病，炎症和免疫疾病，并且具有 式（I）或（II）：其中Q选自N，O和S;其包括其立体异构体，其互变异构体，其前药或其药学上可接受的盐; Y是芳基或杂芳基; Z是H，C 2-6烷基，环烷基，杂环烷基，芳基，杂芳基，卤素或烷氧基; 并且A，B，R，Ra，Rb，Rc和Rd在本文中定义。 还提供了治疗肥胖症，糖尿病和包含所述化合物的炎性或免疫相关疾病的药物组合物和方法。

公开(公告)号：US08013004B2

公开(公告)日：2011-09-06

申请号：US12631179

申请日：2009-12-04

申请人： T. G. Murali Dhar ,  Hai-Yun Xiao ,  Bingwei Yang

发明人： T. G. Murali Dhar ,  Hai-Yun Xiao ,  Bingwei Yang

IPC分类号： C07D277/00 ,  C07D233/00 ,  A01N43/76 ,  A01N43/50

CPC分类号： C07D401/10 ,  C07D249/14 ,  C07D277/46 ,  C07D401/04 ,  C07D401/14 ,  C07D403/10 ,  C07D417/10

摘要： A class of novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity including obesity, diabetes, inflammatory and immune diseases, and have the structure of formula (I) or (II): including a stereoisomer thereof, a tautomer thereof, a prodrug thereof, or a pharmaceutically acceptable salt thereof, where Q is selected from N, O, and S; Y is aryl or heteroaryl; Z is H, C2-6alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, halo, or alkoxy; and A, B, R, Ra, Rb, Rc and Rd are defined herein. Also provided are pharmaceutical compositions and methods of treating obesity, diabetes and inflammatory or immune associated diseases comprising said compounds.

摘要翻译： 提供一类新型非甾体化合物，其可用于治疗与调节糖皮质激素受体，AP-1和/或NF-κB活性相关的疾病，包括肥胖症，糖尿病，炎症和免疫疾病，并且具有 式（I）或（II）的结构：包括其立体异构体，其互变异构体，其前药或其药学上可接受的盐，其中Q选自N，O和S; Y是芳基或杂芳基; Z是H，C 2-6烷基，环烷基，杂环烷基，芳基，杂芳基，卤素或烷氧基; 并且A，B，R，Ra，Rb，Rc和Rd在本文中定义。 还提供了治疗肥胖症，糖尿病和包含所述化合物的炎性或免疫相关疾病的药物组合物和方法。

公开(公告)号：US07994190B2

公开(公告)日：2011-08-09

申请号：US12513228

申请日：2007-10-31

申请人： T. G. Murali Dhar ,  Hai-Yun Xiao ,  James E. Sheppeck

发明人： T. G. Murali Dhar ,  Hai-Yun Xiao ,  James E. Sheppeck

IPC分类号： A61K31/437 ,  C07D401/02

CPC分类号： C07D471/04

摘要： Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, and/or AP-1 and/or NF-κB activity including inflammatory and immune diseases, obesity and diabetes having the structure of formula (I):, its enantiomers, diastereomers, or a pharmaceutically-acceptable salt, or hydrate, thereof, wherein the group X is O or (Rx)(Ry); is heterocyclo or heteroaryl; E is —N—, —NR1—, —O—, —C(═O), —S—, —SO2—, or —CR2—; F is —N—, —NR1a, —O—, —C(═O), —S—, —SO2—, or —CR2a—; G is independently N, —NR1b—, —O—, —C(═O), —S—, —SO2— or —CR2b— provided that the heterocyclic ring formed does not contain a S—S or S—O bond and at least one of E, F and G is a hetero atom; and Ma, Rx, Ry, R1, R1a, R1b, R2, R2a, R2b, R4, R5a, R6, R7, X, Za and Z are as defined herein. Also provided are pharmaceutical compositions and methods of treating inflammatory- or immune-associated diseases employing said compounds.

摘要翻译： 提供了新的非甾体化合物，其可用于治疗与调节糖皮质激素受体，和/或AP-1和/或NF-κB活性相关的疾病，包括具有结构式的炎性和免疫疾病，肥胖症和糖尿病 （I）：其对映体，非对映异构体或其药学上可接受的盐或水合物，其中基团X为O或（Rx）（Ry）; 是杂环基或杂芳基; E是-N-，-NR1-，-O - ， - C（= O）， - S - ， - SO 2 - 或-CR 2 - ; F是-N-，-NR1a，-O-，-C（= O），-S-，-SO2 - 或-CR2a; G独立地为N，-NR1b - ， - O - ， - C（= O）， - S - ， - SO2-或-CR2b-，条件是所形成的杂环不含S-S或S-O键， E，F和G中的至少一个是杂原子; 并且Ma，Rx，Ry，R1，R1a，R1b，R2，R2a，R2b，R4，R5a，R6，R7，X，Za和Z如本文所定义。 还提供了使用所述化合物治疗炎性或免疫相关疾病的药物组合物和方法。